Pinned Tweet
📅 Save the date!
EORTC events are back in 2026 ⬇️
#CancerResearch #ClinicalTrials #Oncology #EORTCevents
📄 New in @Hemasphere_EHA
Researchers from the i-BFM Study Group, including contributors from EORTC, identified favorable subgroups of pediatric high-hyperdiploid ALL in a retrospective multinational study that included data from the EORTC-CLG 58951 trial.
doi.org/10.1002/hem3.70477
#ESMO26 Congress opens tomorrow in Madrid.
EORTC researchers and collaborators will present multidisciplinary research across oral presentations, mini orals, posters, e-posters and trials in progress.
Explore our abstract overview: eortc.org/blog/2026/10/22/eo…
👏 Proud of the strong contribution from the EORTC Quality of Life Group at #ISOQOL 2026, showcasing research that helps strengthen patient-centred cancer care and gives greater visibility to patients' experiences.
👇
#QualityofLife #GivingVoice2Patients #CancerResearch
@ISOQOL
📢 New questionnaires, interpretation guidelines, survivorship tools, paediatric oncology research & initiatives to improve the use of PROs: discover the key @EORTC #QualityofLife Group research presented at #ISOQOL 2026.
🔗 eortc.org/blog/2026/10/21/eo…
#GivingVoice2Patients
@ISOQOL
🎀 #PinkOctober: Can genomic testing help avoid unnecessary chemotherapy in breast cancer? Meet Betty, a participant in the MINDACT study.
Learn more: eortc.org/blog/2026/10/07/pi…
🎥 Watch her story:
@JulesBordet
#MINDACT #EORTCbreast
EORTC retweeted
📖 Yesterday afternoon at #ISOQOL, @monika_sztankay presented the @EORTC Patient-Reported Outcome Interpretation Guideline.
The project also introduces new resources to help patients understand EORTC PRO data, coming soon on our website.
#GivingVoice2Patients #QualityofLife
What does it take to move from protocol to patient?
Today at @EANM_NucMed 2026, our past president, @Winette_vdGraaf, shared practical lessons from multinational academic clinical trials across Europe drawing on years of experience in international cancer research.
#EANM26
EORTC retweeted
💡 This afternoon at #ISOQOL, Andreia Moura shared findings on how to improve PROM completion in cancer clinical trials.
Key takeaways: reduce questionnaire redundancy, support patients, and ensure site staff understands the value of PRO data collection.
#GivingVoice2Patients
📊 We're hiring a Senior Statistician to support the design, analysis and reporting of international clinical trials at EORTC.
Join a multidisciplinary team advancing cancer research through data-driven science.
🔗 Apply now: eortc.org/job/senior-statist…
#ClinicalTrials
📍 At #EANM26? Visit EORTC at booth 11 in the Society Village!
Don't miss our Joint Symposium today at 15:00 in Hall F2 on clinical trial design for RLTs.
@EANM_NucMed
#ClinicalTrials #CancerResearch #RadioligandTherapy #RLT #Oncology
📢 EORTC is at #EANM26!
Among the programme highlights are a joint symposium with the EANM Oncology & Theranostics Committee on evidence generation for radioligand therapies and a presentation by Winette Van der Graaf on multinational academic trials across Europe.
@EANM_NucMed
50 years of supporting progress in cancer research!
Relive the highlights of the EORTC Cancer Research Fund's anniversary Gala Dinner and celebrate five decades of impact.
Watch the aftermovie: ow.ly/FZF150ZYsYU
#EORTC #ECRF #CancerResearch
🚨 Final days to submit your LBA!
Last chance to share your latest research with the ENA community.
Deadline: This Monday
👉 Submit now: event.eortc.org/ena2026/late…
@AACR @theNCI
#ENASymp26 #CancerResearch #Oncology
Proud to see the EORTC Quality of Life Group presenting 16 abstracts at #ISOQOL 2026 next week, contributing to advances in patient-centred cancer research.👇
#QualityofLife #GivingVoice2Patients #CancerResearch @ISOQOL
We are looking forward to #ISOQOL 2026 in Prague! 🇨🇿
The @EORTC #QualityofLife Group will present 16 abstracts (6 oral, 10 poster) showcasing advances in PRO & HRQoL research, paediatric oncology, survivorship and questionnaire development.
🔗 eortc.org/blog/2026/10/15/eo…
@ISOQOL
📢 We're hiring an EU Grant Officer.
If you have experience with EU-funded projects and enjoy working in an international research environment, we'd like to hear from you.
🔗Apply here: eortc.org/job/eu-grant-offic…
#Hiring #EORTC #CancerResearch #EUJobs
How can Europe better support low-risk, treatment optimisation trials?
Among the Top 3 abstracts at the ECO Summit, this new EORTC study compares EU, UK and Swiss frameworks for low-intervention clinical trials and calls for more proportionate regulation.
doi.org/10.1016/j.ejca.2026.…
🎀#PinkOctober: How do treatment decisions impact patients decades later?
EORTC-22922/10925 trial: 20-year follow-up includes a node-negative analysis published in @TheLancetOncol, exploring regional lymph node irradiation.
🎥Watch now
🔗eortc.org/blog/2026/10/07/pi…
#EORTCbreast
📢 We're hiring a Medical Liaison Officer (MLO)!
Join the EORTC Medical Department and help support our scientific groups, committees and international cancer research activities.
🔗 Apply here: eortc.org/job/medical-liaiso…
#WeAreHiring #CancerResearch
Europe's leadership in biotechnology depends on turning innovation into real-world patient benefit.
EORTC CEO Denis Lacombe is participating in today's Expert Dialogue on the EU Biotech Act at the @Europarl_EN, bringing the academic cancer research perspective.
